Amneal Pharmaceuticals, Inc. (AMRX)
17.54
-0.47
(-2.61%)
USD |
NASDAQ |
Aug 28, 16:00
17.53
-0.01
(-0.06%)
After-Hours: 20:00
Amneal Pharmaceuticals Free Cash Flow : -14.29M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.29M |
| March 31, 2026 | 186.11M |
| December 31, 2025 | 225.64M |
| September 30, 2025 | 236.43M |
| June 30, 2025 | 261.51M |
| March 31, 2025 | 233.29M |
| December 31, 2024 | 220.04M |
| September 30, 2024 | 67.35M |
| June 30, 2024 | 13.66M |
| March 31, 2024 | -38.17M |
| December 31, 2023 | 113.97M |
| September 30, 2023 | 136.96M |
| June 30, 2023 | 112.26M |
| March 31, 2023 | 39.32M |
| December 31, 2022 | -23.11M |
| September 30, 2022 | 56.21M |
| June 30, 2022 | 85.26M |
| March 31, 2022 | 121.59M |
| December 31, 2021 | 192.39M |
| September 30, 2021 | 223.15M |
| June 30, 2021 | 183.02M |
| March 31, 2021 | 413.95M |
| December 31, 2020 | 318.21M |
| September 30, 2020 | 187.22M |
| June 30, 2020 | 282.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 71.28M |
| December 31, 2019 | -95.73M |
| September 30, 2019 | 199.56M |
| June 30, 2019 | 97.35M |
| March 31, 2019 | 19.21M |
| December 31, 2018 | 153.14M |
| September 30, 2018 | -40.81M |
| June 30, 2018 | -32.03M |
| March 31, 2018 | 97.14M |
| December 31, 2017 | 119.92M |
| September 30, 2017 | 33.53M |
| June 30, 2017 | 62.72M |
| March 31, 2017 | -11.07M |
| December 31, 2016 | 21.70M |
| September 30, 2016 | 88.47M |
| June 30, 2016 | 87.26M |
| March 31, 2016 | 84.52M |
| December 31, 2015 | 40.88M |
| September 30, 2015 | -14.25M |
| June 30, 2015 | -47.86M |
| March 31, 2015 | 38.20M |
| December 31, 2014 | -10.10M |
| September 30, 2014 | -6.918M |
| June 30, 2014 | -52.06M |
| March 31, 2014 | 27.91M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Liquidia Corp. | 150.69M |
| Eli Lilly & Co. | 13.56B |
| Viatris, Inc. | 1.806B |
| Pfizer Inc. | 10.99B |
| Indivior Pharmaceuticals, Inc. | -119.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.24M |
| Cash from Investing (Quarterly) | -123.14M |
| Cash from Financing (Quarterly) | 79.76M |
| Free Cash Flow Per Share (Quarterly) | -0.4388 |
| Free Cash Flow to Equity (Quarterly) | -239.26M |
| Free Cash Flow to Firm (Quarterly) | -90.01M |
| Free Cash Flow Yield | -0.25% |